Greg Freiherr, Industry Consultant
Greg Freiherr, Industry Consultant

Greg Freiherr has reported on developments in radiology since 1983. He runs the consulting service, The Freiherr Group.

Blog | Greg Freiherr, Industry Consultant | March 22, 2013

MR “Fingerprinting” Promises Quick Screen for Disease

Only one radiological modality – mammography – is used today for screening. Yet, as America hurdles toward preventive medicine, screening is where it will be at. Now researchers in Cleveland are floating the idea of using MRI as a standard procedure in annual checkups. 

This is not the MRI of the present, which sequesters patients inside a superconducting magnet for a half hour or more. This is a quick, radically new kind of MR – the MR equivalent of fingerprinting – that might one day scan whole patients for early signs of cancer, multiple sclerosis and heart disease in just a few minutes. And it can be done on a standard high-field scanner.

One of the investigators, Mark Griswold, Ph.D., a radiology professor at Case Western Reserve School of Medicine, says he and his colleagues “had to give up everything we knew about MRI and start over.”

Their work appeared March 13 in the online edition of the UK journal Nature, itself a nontraditional way of getting the word out on a radiological development. The president and CEO of Siemens Healthcare North America, which has been underwriting the research, believes this new technique could have broad ramifications for patients in five or ten years.

It’s taken a decade for the Cleveland team to get where they are now, doing much of the developmental work on a Siemens Espree 1.5T scanner. Scans done with the new technique reveal a fingerprint of tissue health, Griswold says, comprised of what might appear to be a cacophony of MR signals. These are produced by varying different parts of the electromagnetic fields that the Cleveland researchers use to probe the tissue. The signals carry information about key physical properties of the tissues. The signals are analyzed, quantified and charted to reveal patterns associated with health or specific diseases and their degree of progression.

In their Nature paper, the researchers report that MR fingerprinting “provides an alternative way to quantitatively detect and analyze complex changes that can represent physical alterations of a substance or early indicators of disease.”

If their preliminary results hold up, MR fingerprinting would be the first truly novel development coming out of MR in decades. And the timing couldn’t be better, given the push for healthcare reform and its emphasis on cost reduction, disease prevention and early treatment. 

Related Content

Imago Systems Announces Collaboration With Mayo Clinic for Breast Imaging

Image courtesy of Imago Systems

News | Mammography | August 14, 2019
Image visualization company Imago Systems announced it has signed a know-how license with Mayo Clinic. The multi-year...
Volpara to Distribute Screenpoint Medical's Transpara AI Solution
News | Breast Imaging | August 02, 2019
Volpara Solutions and ScreenPoint Medical BV signed an agreement under which Volpara will sell ScreenPoint's Transpara...
Ikonopedia Releases Automated Combined Reporting Package at AHRA
News | Mammography Reporting Software | July 26, 2019
Ikonopedia showcased its recently released Automated Combined Reporting package and its entire suite of structured...
Hologic Partners With MagView to Develop Unifi EQUIP Solution
Technology | Mammography Reporting Software | July 25, 2019
Hologic announced a partnership with mammography information solutions provider MagView to develop Unifi EQUIP, an...
Fujifilm Releases Tomosynthesis Biopsy Option for Aspire Cristalle Mammography System
Technology | Breast Biopsy Systems | July 24, 2019
Fujifilm Medical Systems U.S.A. Inc. recently expanded its breast imaging solutions with the launch of its...
IBM collected a dataset of 52,936 images from 13,234 women who underwent at least one mammogram between 2013 and 2017.

IBM collected a dataset of 52,936 images from 13,234 women who underwent at least one mammogram between 2013 and 2017, and who had health records for at least one year prior to the mammogram. The algorithm was trained on 9,611 mammograms. Image courtesy of Radiology.

Feature | Artificial Intelligence | July 19, 2019 | Michal Chorev
Breast cancer is the global leading cause of cancer-related deaths in women, and the most commonly diagnosed cancer...
Paragon Biosciences Launches Qlarity Imaging to Advance FDA-cleared AI Breast Cancer Diagnosis System

Qlarity Imaging’s software is used to assist radiologists in the assessment and characterization of breast lesions. Imaging features are synthesized by an artificial intelligence algorithm into a single value, the QI score, which is analyzed relative to a database of reference abnormalities with known ground truth. Image courtesy of Business Wire.

Technology | Artificial Intelligence | July 18, 2019
Paragon Biosciences LLC announced the launch of its seventh portfolio company, Qlarity Imaging LLC, which was founded...
SimonMed Imaging Implements ProFound AI for 3-D Tomosynthesis
News | Mammography | July 10, 2019
Arizona-based SimonMed Imaging announced their implementation of the first U.S. Food and Drug Administration (FDA)-...
Therapixel Appoints Matthieu Leclerc-Chalvet as CEO
News | Artificial Intelligence | July 03, 2019
Artificial intelligence (AI) breast cancer screening specialist Therapixel announced the appointment of Matthieu...